Annual Net Margin
-188.90%
+420.56%+69.01%
December 31, 2023
Summary
- As of February 7, 2025, ADAP annual net profit margin is -188.90%, with the most recent change of +420.56% (+69.01%) on December 31, 2023.
- During the last 3 years, ADAP annual net margin has risen by +3097.91% (+94.25%).
- ADAP annual net margin is now -2443.67% below its all-time high of 8.06%, reached on December 1, 2013.
Performance
ADAP Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-43.07%
-97.29%-179.44%
September 30, 2024
Summary
- As of February 7, 2025, ADAP quarterly net profit margin is -43.07%, with the most recent change of -97.29% (-179.44%) on September 30, 2024.
- Over the past year, ADAP quarterly net margin has increased by +811.16% (+94.96%).
- ADAP quarterly net margin is now -179.44% below its all-time high of 54.22%, reached on June 30, 2024.
Performance
ADAP Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
ADAP Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.0% | +95.0% |
| 3 y3 years | +94.3% | +98.8% |
| 5 y5 years | -17.7% | +99.7% |
ADAP Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +92.7% | -179.4% | +99.8% |
| 5 y | 5-year | at high | +98.5% | -179.4% | +99.8% |
| alltime | all time | -2443.7% | +98.5% | -179.4% | +99.8% |
Adaptimmune Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -43.07%(-179.4%) |
| Jun 2024 | - | 54.22%(-106.3%) |
| Mar 2024 | - | -854.23%(-95.9%) |
| Dec 2023 | -188.90%(-69.0%) | -20.74 K%(+3229.3%) |
| Sep 2023 | - | -623.05%(+49.4%) |
| Jun 2023 | - | -416.94%(<-9900.0%) |
| Mar 2023 | - | 2.18%(-100.8%) |
| Dec 2022 | -609.46%(-76.3%) | -265.23%(-55.1%) |
| Sep 2022 | - | -591.14%(-26.5%) |
| Jun 2022 | - | -803.90%(-42.8%) |
| Mar 2022 | - | -1406.01%(-48.7%) |
| Dec 2021 | -2570.99%(-21.8%) | -2742.27%(-22.2%) |
| Sep 2021 | - | -3524.61%(+179.2%) |
| Jun 2021 | - | -1262.29%(-85.5%) |
| Mar 2021 | - | -8701.15%(+257.0%) |
| Dec 2020 | -3286.81%(-73.1%) | -2437.62%(-17.9%) |
| Sep 2020 | - | -2969.99%(-50.1%) |
| Jun 2020 | - | -5952.19%(+60.8%) |
| Mar 2020 | - | -3701.31%(-8.2%) |
| Dec 2019 | -12.23 K% | -4033.52%(-75.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -16.58 K%(-36.6%) |
| Jun 2019 | - | -26.17 K%(+970.0%) |
| Dec 2018 | -160.51%(-13.4%) | -2445.77%(<-9900.0%) |
| Sep 2018 | - | 12.85%(-102.6%) |
| Jun 2018 | - | -485.12%(+88.6%) |
| Mar 2018 | - | -257.17%(-59.7%) |
| Dec 2017 | -185.39%(-63.2%) | -638.48%(>+9900.0%) |
| Sep 2017 | - | -3.23%(-99.4%) |
| Jun 2017 | - | -574.13%(-24.7%) |
| Mar 2017 | - | -762.41%(+322.2%) |
| Dec 2016 | -504.15%(+96.8%) | -180.58%(-76.4%) |
| Sep 2016 | - | -765.48%(-88.6%) |
| Jun 2016 | - | -6736.28%(+1162.0%) |
| Mar 2016 | - | -533.79%(+1447.2%) |
| Dec 2015 | -256.15%(+14.6%) | - |
| Sep 2015 | - | -34.50%(-50.8%) |
| Jun 2015 | -223.46%(-84.1%) | - |
| Dec 2014 | - | -70.19%(-67.1%) |
| Sep 2014 | - | -213.03% |
| Jun 2014 | -1406.18%(<-9900.0%) | - |
| Dec 2013 | 8.06% | - |
FAQ
- What is Adaptimmune Therapeutics annual net profit margin?
- What is the all time high annual net margin for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual net margin year-on-year change?
- What is Adaptimmune Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly net margin year-on-year change?
What is Adaptimmune Therapeutics annual net profit margin?
The current annual net margin of ADAP is -188.90%
What is the all time high annual net margin for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual net profit margin is 8.06%
What is Adaptimmune Therapeutics annual net margin year-on-year change?
Over the past year, ADAP annual net profit margin has changed by +420.56% (+69.01%)
What is Adaptimmune Therapeutics quarterly net profit margin?
The current quarterly net margin of ADAP is -43.07%
What is the all time high quarterly net margin for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly net profit margin is 54.22%
What is Adaptimmune Therapeutics quarterly net margin year-on-year change?
Over the past year, ADAP quarterly net profit margin has changed by +811.16% (+94.96%)